Log in

Surgery Partners Stock Forecast, Price & News

-0.10 (-0.42 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $23.52
50-Day Range
MA: $19.41
52-Week Range
Now: $23.52
Volume516,258 shs
Average Volume706,985 shs
Market Capitalization$1.19 billion
P/E RatioN/A
Dividend YieldN/A
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of December 31, 2018, the company owned or operated a portfolio of 123 surgical facilities, including 108 ambulatory surgical centers and 15 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Read More
Surgery Partners logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Current SymbolNASDAQ:SGRY



Sales & Book Value

Annual Sales$1.83 billion
Cash Flow$0.55 per share
Book Value$19.67 per share


Net Income$-74,800,000.00


Market Cap$1.19 billion
Next Earnings Date11/3/2020 (Estimated)
-0.10 (-0.42 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

How has Surgery Partners' stock price been impacted by Coronavirus (COVID-19)?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SGRY stock has increased by 165.5% and is now trading at $23.52.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Surgery Partners?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Surgery Partners

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Surgery Partners

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.55) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.57) by $0.02. The firm earned $374.70 million during the quarter, compared to analysts' expectations of $370.17 million. Surgery Partners had a negative net margin of 5.26% and a negative return on equity of 3.23%.
View Surgery Partners' earnings history

What price target have analysts set for SGRY?

5 equities research analysts have issued 12 month price objectives for Surgery Partners' shares. Their forecasts range from $17.50 to $28.00. On average, they expect Surgery Partners' share price to reach $23.30 in the next year. This suggests that the stock has a possible downside of 0.9%.
View analysts' price targets for Surgery Partners

Are investors shorting Surgery Partners?

Surgery Partners saw a decrease in short interest in August. As of August 14th, there was short interest totaling 2,550,000 shares, a decrease of 23.0% from the July 30th total of 3,310,000 shares. Based on an average daily trading volume, of 589,600 shares, the short-interest ratio is currently 4.3 days. Currently, 11.2% of the shares of the company are sold short.
View Surgery Partners' Short Interest

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Ocular Therapeutix (OCUL), Rigel Pharmaceuticals (RIGL), Tesla (TSLA), Xilinx (XLNX), Editas Medicine (EDIT), Novavax (NVAX), Sangamo Therapeutics (SGMO), Verizon Communications (VZ) and Allena Pharmaceuticals (ALNA).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.48%), FMR LLC (2.33%), WCM Investment Management LLC (0.87%), Point72 Asset Management L.P. (0.81%), Bank of Montreal Can (0.74%) and Bridgeway Capital Management Inc. (0.57%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Jason Eric Evans and Teresa Deluca.
View institutional ownership trends for Surgery Partners

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., FMR LLC, Nuveen Asset Management LLC, Strs Ohio, Bank of New York Mellon Corp, UBS Group AG, California Public Employees Retirement System, and American International Group Inc..
View insider buying and selling activity for Surgery Partners

Which institutional investors are buying Surgery Partners stock?

SGRY stock was acquired by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Vanguard Group Inc., Point72 Asset Management L.P., Bridgeway Capital Management Inc., Dupont Capital Management Corp, Cannell Peter B & Co. Inc., Park Avenue Institutional Advisers LLC, and Quantitative Systematic Strategies LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca.
View insider buying and selling activity for Surgery Partners

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $23.52.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $1.19 billion and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis. Surgery Partners employs 9,600 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is www.surgerypartners.com.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.